# RIVAROXABAN
> **ANDA218427** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2026-03-02
## Drug
- **FDA Application Number:** ANDA218427
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVAROXABAN
- **Generic name:** Rivaroxaban
- **Active ingredients:** RIVAROXABAN
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **First approval:** 2026-03-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218427)
---
*AI Analytics · CC0 1.0*